Using additional substances that influence appetite, blood sugar, digestion, or body composition may increase side effects or make it more difficult to evaluate your response to the primary medication
BPC-157 triggers a specific chemical signal (Src-Caveolin-1 phosphorylation) that unlocks this enzyme, allowing a controlled release of nitric oxide to start the healing process
NaBPC157 (10 g or 10 ng/kg b.w., i.p., i.g.) was given prophylactically 1 hour before ligation, whereas the therapy was conducted by adaily application1 day after ligation (last application 24 hours before sacrifice)
FVII activity Factor VII (FVII) activity in the cell medium was determined using the Human FVII Chromogenic Activity Kit (Nordic BioSite AB, Tby, Sweden) according to the manufacturers instructions
Improved glucose regulation Enhances insulin sensitivity and reduces metabolic inflammation